CDY.AX - Cellmid Limited

ASX - ASX Delayed Price. Currency in AUD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
6/30/2019
6/30/2018
6/30/2017
6/30/2016
Total Revenue
-
7,302
5,648
4,496
3,120
Cost of Revenue
-
2,137
-
-
-
Gross Profit
-
5,164
5,648
4,496
3,120
Operating Expenses
Research Development
-
848
598
600
355
Selling General and Administrative
-
7,093
6,797
6,427
5,827
Total Operating Expenses
-
11,860
10,092
9,642
7,903
Operating Income or Loss
-
-6,696
-4,444
-5,146
-4,783
Interest Expense
235
-
473
291
196
Total Other Income/Expenses Net
-
969
1,153
945
1,451
Income Before Tax
-5,885
-
-3,730
-4,435
-3,488
Income Tax Expense
24
-
2
36
11
Income from Continuing Operations
-5,910
-
-3,733
-4,470
-3,499
Net Income
-5,910
-
-3,733
-4,470
-3,499
Net Income available to common shareholders
-5,910
-
-3,733
-4,470
-3,499
Reported EPS
Basic
-
-
-0.07
-0.09
-0.08
Diluted
-
-
-0.07
-0.09
-0.08
Weighted average shares outstanding
Basic
-
-
55,380
51,008
45,507
Diluted
-
-
55,380
51,008
45,507
EBITDA
-
-
-3,069
-3,987
-3,130